HEPATIC CANCER RECURRENT

HEPATIC CANCER RECURRENT was reported 284 times

HEPATIC CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ileal Bile Acid Transporter Inhibitor [EPC] 1 0.0022
1 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 88 0.0017
2 Hepatitis C Virus NS5A Inhibitor [EPC] 51 0.0011
3 Nucleoside Analog Antiviral [EPC] 44 0.0005
4 Somatostatin Analog [EPC] 2 0.0003
5 Stimulant Laxative [EPC] 4 0.0003
6 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
7 Vitamin D3 Analog [EPC] 4 0.0002
8 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 4 0.0002
9 Programmed Death Ligand-1 Blocker [EPC] 4 0.0002
10 Provitamin D2 Compound [EPC] 4 0.0001
11 Vasopressin V2 Receptor Antagonist [EPC] 2 0.0001
12 HER2/neu Receptor Antagonist [EPC] 10 0.0001
13 Dopamine-2 Receptor Antagonist [EPC] 1 0.0001
14 Epidermal Growth Factor Receptor Antagonist [EPC] 6 0.0001
15 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 2 0.0001
16 Methylxanthine [EPC] 6 0.0001
17 Estrogen Receptor Antagonist [EPC] 4 0.0001
18 Bile Acid [EPC] 2 0.0001
19 Platinum-based Drug [EPC] 21 0.0001
20 Nucleoside Metabolic Inhibitor [EPC] 21 0.0001
21 Vascular Endothelial Growth Factor Inhibitor [EPC] 13 0.0001
22 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
23 Central Nervous System Stimulant [EPC] 5 0.0001
24 Microtubule Inhibitor [EPC] 9 0.0001
25 Topoisomerase Inhibitor [EPC] 4 0.0001
26 Programmed Death Receptor-1 Blocking Antibody [EPC] 5 0.0001
27 Histamine-1 Receptor Antagonist [EPC] 4 0.0000
28 Kinase Inhibitor [EPC] 24 0.0000
29 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
30 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
31 Interleukin-23 Antagonist [EPC] 4 0.0000
32 Aromatase Inhibitor [EPC] 4 0.0000
33 Phenothiazine [EPC] 1 0.0000
34 alpha-Adrenergic Blocker [EPC] 4 0.0000
35 Sulfonylurea [EPC] 3 0.0000
36 Proton Pump Inhibitor [EPC] 14 0.0000
37 beta-Adrenergic Blocker [EPC] 7 0.0000
38 Insulin [EPC] 1 0.0000
39 Dihydropyridine Calcium Channel Blocker [EPC] 7 0.0000
40 Aminosalicylate [EPC] 2 0.0000
41 Vitamin D [EPC] 6 0.0000
42 Interleukin-12 Antagonist [EPC] 2 0.0000
43 Aldosterone Antagonist [EPC] 3 0.0000
44 Azole Antifungal [EPC] 3 0.0000
45 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
46 Vitamin B12 [EPC] 6 0.0000
47 Opioid Agonist [EPC] 5 0.0000
48 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
49 Vitamin C [EPC] 7 0.0000
50 Alkylating Drug [EPC] 4 0.0000
51 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
52 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
53 Osmotic Laxative [EPC] 4 0.0000
54 Androgen Receptor Inhibitor [EPC] 1 0.0000
55 Insulin Analog [EPC] 6 0.0000
56 Corticosteroid [EPC] 17 0.0000
57 Loop Diuretic [EPC] 6 0.0000
58 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
59 Integrin Receptor Antagonist [EPC] 1 0.0000
60 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
61 Purine Antimetabolite [EPC] 1 0.0000
62 RANK Ligand Inhibitor [EPC] 2 0.0000
63 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
64 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
65 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
66 Parathyroid Hormone Analog [EPC] 1 0.0000
67 Proteasome Inhibitor [EPC] 1 0.0000
68 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
69 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
70 Fluoroquinolone Antibacterial [EPC] 1 0.0000
71 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
72 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
73 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
74 Calcium [EPC] 1 0.0000
75 Janus Kinase Inhibitor [EPC] 1 0.0000
76 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
77 Platelet Aggregation Inhibitor [EPC] 3 0.0000
78 Interferon beta [EPC] 1 0.0000
79 Endothelin Receptor Antagonist [EPC] 1 0.0000
80 Thiazide Diuretic [EPC] 1 0.0000
81 Benzodiazepine [EPC] 3 0.0000
82 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
83 Factor Xa Inhibitor [EPC] 1 0.0000
84 GLP-1 Receptor Agonist [EPC] 1 0.0000
85 Thalidomide Analog [EPC] 1 0.0000